
Puma Biotechnology PBYI
€ 7.65
1.38%
Puma Biotechnology EV/EBITDA | PBYI
EV/EBITDA Jährlich Puma Biotechnology
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.01 | 4.64 | 8.72 | 8.89 | 24.2 | -23.4 | -11.7 | -12.2 | -8.32 | -3 | -5.47 | -44.4 | -64.7 | -5.25 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 24.2 | -64.7 | -8.8 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Celsion Corporation
CLSN
|
0.248 | - | -6.63 % | $ 13.9 M | ||
|
FSD Pharma
HUGE
|
-0.271 | - | 5743.5 % | $ 69.7 M | ||
|
Qilian International Holding Group Limited
QLI
|
-2.89 | - | -6.08 % | $ 184 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-0.984 | - | 1.35 % | $ 17.8 M | ||
|
Synthetic Biologics
SYN
|
-0.409 | - | 1.32 % | $ 16.2 M | ||
|
Dynavax Technologies Corporation
DVAX
|
4.01 K | - | - | $ 2.02 B | ||
|
BioXcel Therapeutics
BTAI
|
-2.54 | $ 1.19 | 5.31 % | $ 14.5 M | ||
|
Burford Capital Limited
BUR
|
24.7 | $ 4.37 | 0.23 % | $ 958 M | ||
|
I-Mab
IMAB
|
-37.7 | - | - | $ 866 M | ||
|
BeyondSpring
BYSI
|
-12.6 | $ 0.84 | 34.27 % | $ 34.5 M | ||
|
Corner Growth Acquisition Corp.
COOL
|
-55 | - | -0.89 % | $ 114 M | ||
|
AgeX Therapeutics
AGE
|
-0.164 | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
4.22 K | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-12.1 | - | -13.47 % | $ 169 M | ||
|
Cerus Corporation
CERS
|
-87.2 | $ 2.98 | 4.93 % | $ 568 M | ||
|
Compugen Ltd.
CGEN
|
3.32 | $ 2.41 | 4.17 % | $ 225 M | ||
|
CureVac N.V.
CVAC
|
-2.11 | - | - | $ 867 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
0.0485 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
8.55 | - | 0.74 % | $ 768 M | ||
|
Abcam plc
ABCM
|
-513 | - | - | $ 4.9 B | ||
|
Завод ДИОД
DIOD
|
7.12 | - | - | - | ||
|
Galera Therapeutics
GRTX
|
2.25 | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
0.204 | - | -18.52 % | $ 27.3 M | ||
|
Hepion Pharmaceuticals
HEPA
|
0.252 | - | -18.79 % | $ 39.3 K | ||
|
ARCA biopharma
ABIO
|
0.248 | - | 1052.0 % | $ 415 M | ||
|
MorphoSys AG
MOR
|
-9.67 | - | 2.43 % | $ 254 M | ||
|
Champions Oncology
CSBR
|
392 | $ 5.1 | 2.63 % | $ 70.5 M | ||
|
Affimed N.V.
AFMD
|
0.361 | - | -34.95 % | $ 21.5 M | ||
|
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
-2.15 | - | -1.58 % | $ 28.1 M | ||
|
Celyad Oncology SA
CYAD
|
0.0447 | - | - | $ 12.5 M | ||
|
Adial Pharmaceuticals
ADIL
|
0.407 | $ 3.98 | 1.86 % | $ 2.66 M | ||
|
Generation Bio Co.
GBIO
|
-0.5 | - | - | $ 344 M | ||
|
Akero Therapeutics
AKRO
|
-10.5 | - | - | $ 3.67 B | ||
|
AnaptysBio
ANAB
|
26.4 | $ 58.47 | 4.37 % | $ 1.68 B | ||
|
Anika Therapeutics
ANIK
|
-27.5 | $ 21.5 | 1.56 % | $ 308 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
0.257 | - | -4.36 % | $ 27 M | ||
|
Gracell Biotechnologies
GRCL
|
2.07 | - | - | $ 3.37 B | ||
|
Aurinia Pharmaceuticals
AUPH
|
37 | $ 15.47 | 1.91 % | $ 2.08 B | ||
|
GlycoMimetics
GLYC
|
1.15 | - | 9357.83 % | $ 1.01 B | ||
|
Aeterna Zentaris
AEZS
|
-0.963 | - | 5.93 % | $ 314 M | ||
|
AVROBIO
AVRO
|
2.95 | - | 1083.1 % | $ 745 M | ||
|
BeiGene, Ltd.
BGNE
|
-1.22 | - | 0.49 % | $ 251 B | ||
|
Bicycle Therapeutics plc
BCYC
|
0.703 | $ 3.9 | 0.24 % | $ 270 M | ||
|
Beam Therapeutics
BEAM
|
-8.71 | $ 26.75 | 0.91 % | $ 2.65 B | ||
|
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | ||
|
Aeglea BioTherapeutics
AGLE
|
0.111 | - | - | $ 1.01 B | ||
|
BioMarin Pharmaceutical
BMRN
|
24.3 | $ 67.36 | 0.99 % | $ 12.9 B | ||
|
Aptose Biosciences
APTO
|
1.65 K | - | -45.71 % | $ 1.2 M |